[Therapy of ischemic heart disease with Trapidil. Observations with 4,014 patients in medical practice].
METHODS
Within the framework of a user observations study, 4,014 patients with ischemic heart disease were treated with Trapidil and kept under observation for 12 weeks.


RESULTS
During the course of therapy, a decrease in the incidence and intensity of attacks of angina pectoris and in the number of weekly short-term nitrate applications was observed. Side effects, most commonly nausea, headache, GI complaints and giddiness, were reported by only 3.8% of the patients. The efficacy of the preparation was assessed to be good or very good in more than 89%, tolerability in more than 90%, of the cases. These results are in accord with the assessment in reports in the international literature to the effect that Trapidil has a good therapeutic action.
Lohr
E
E
D000787:Angina Pectoris / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy*; D017277:Drug Approval; D005500:Follow-Up Studies; D005858:Germany; D006801:Humans; D014192:Trapidil / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014192:Trapidil
Therapie der ischämischen Herzkrankheit mit Trapidil. Anwendungsbeobachtung an 4,014 Patienten in der ärztlichen Praxis.